KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Biogen (BIIB) Receivables - Other (2018 - 2023)

Biogen (BIIB) has 9 years of Receivables - Other data on record, last reported at $6.3 million in Q1 2023.

  • For Q1 2023, Receivables - Other rose 8.62% year-over-year to $6.3 million; the TTM value through Mar 2023 reached $6.3 million, up 8.62%, while the annual FY2022 figure was $2.0 million, 51.22% down from the prior year.
  • Receivables - Other reached $6.3 million in Q1 2023 per BIIB's latest filing, up from $2.0 million in the prior quarter.
  • Across five years, Receivables - Other topped out at $250.8 million in Q2 2022 and bottomed at $1.8 million in Q3 2022.
  • Average Receivables - Other over 5 years is $34.8 million, with a median of $5.1 million recorded in 2020.
  • Peak YoY movement for Receivables - Other: plummeted 94.0% in 2020, then grew 8.62% in 2023.
  • A 5-year view of Receivables - Other shows it stood at $85.0 million in 2019, then tumbled by 94.0% to $5.1 million in 2020, then dropped by 19.61% to $4.1 million in 2021, then crashed by 51.22% to $2.0 million in 2022, then skyrocketed by 215.0% to $6.3 million in 2023.
  • Per Business Quant database, its latest 3 readings for Receivables - Other were $6.3 million in Q1 2023, $2.0 million in Q4 2022, and $1.8 million in Q3 2022.